Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

225
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
225
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

1.8K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.8K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

163
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
163
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

93
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
93
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

186
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
186
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

188
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
188

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Premature Ventricular Complexes After Atrial Fibrillation Ablation: Impact of Extensive Ablation Strategies and Vein of Marshall Ethanol.

JACC. Clinical electrophysiology·2026
Same author

Vein of Marshall Ethanol Infusion in Atrial Fibrillation.

JACC. Clinical electrophysiology·2026
Same author

Reablation of atrial fibrillation targeting electrogram dispersion in patients with isolated veins: The RESTART trial.

Heart rhythm·2026
Same author

Unipolar voltage mapping to predict lesion durability during pulsed field ablation.

Heart rhythm·2026
Same author

Accessory Pathway Ablation Via Vein of Marshall Ethanol Infusion: A Case Report of Successful Treatment for Refractory Orthodromic Atrioventricular Re-Entrant Tachycardia.

JACC. Clinical electrophysiology·2026
Same author

Phrenic Nerve Stimulation for Central Sleep Apnoea: When and Why?

Cardiac failure review·2026

Related Experiment Video

Updated: Nov 2, 2025

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

15.0K

Alcohol Ablation for Ventricular Tachycardia.

Adi Lador1, Akanibo Da-Wariboko1, Liliana Tavares1

  • 1Houston Methodist Debakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas.

Methodist Debakey Cardiovascular Journal
|June 9, 2021
PubMed
Summary

Radiofrequency ablation for ventricular tachycardia (VT) often fails for intramural substrates. Alcohol ablation offers an alternative for these refractory VT cases, reviewing its mechanisms and outcomes.

Keywords:
LV summitalcohol ablationventricular tachycardia

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.9K

Related Experiment Videos

Last Updated: Nov 2, 2025

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

15.0K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.9K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Interventional Cardiology

Background:

  • Catheter-based radiofrequency (RF) ablation is a standard treatment for ventricular tachycardia (VT).
  • Recurrent VT remains a challenge, especially when the arrhythmogenic substrate is intramural and difficult to reach with standard ablation catheters.
  • Existing endocardial and epicardial approaches have limitations in accessing certain VT substrates.

Purpose of the Study:

  • To review the evidence on alcohol ablation techniques for ventricular arrhythmias.
  • To discuss the mechanisms, procedural details, and clinical outcomes of alcohol ablation for refractory VT.
  • To evaluate alcohol ablation as an alternative for VT cases unresponsive to RF ablation.

Main Methods:

  • Review of existing literature on alcohol ablation for VT.
  • Analysis of mechanisms underlying alcohol ablation efficacy.
  • Examination of procedural aspects of transarterial and retrograde coronary venous ethanol ablation.
  • Evaluation of reported outcomes and success rates of alcohol ablation therapies.

Main Results:

  • Alcohol ablation, including transarterial and retrograde coronary venous approaches, has emerged as an option for RF-refractory VT.
  • These techniques target intramural substrates inaccessible by conventional methods.
  • Evidence suggests feasibility and potential efficacy, though outcomes vary based on technique and patient selection.

Conclusions:

  • Alcohol ablation represents a viable alternative strategy for managing ventricular tachycardia when conventional RF ablation is unsuccessful.
  • Understanding the mechanisms and procedural nuances is crucial for optimizing alcohol ablation outcomes.
  • Further research may clarify the role of alcohol ablation in the treatment algorithm for complex ventricular arrhythmias.